Related Experiment Video

Updated: Dec 27, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.3K

Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors

Anita Bakrania1,2,3, Mélanie Aubé4, Roxane Desjardins1,2,3

  • 1Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.

Canadian Journal of Physiology and Pharmacology
|March 3, 2020
PubMed

Insights

E2F transcription factors do not regulate PACE4 expression in prostate cancer. This finding challenges previous assumptions about the transcriptional control of this emerging therapeutic target, impacting future research directions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Prostate cancer research identifies PACE4, a proprotein convertase, as a therapeutic target.
  • The oncogenic PACE4-altCT isoform is implicated in tumor progression, with its inhibition showing promise in preclinical models.
  • Transcriptional regulation of PACE4 isoforms remains poorly understood, despite its therapeutic relevance.

Purpose of the Study:

  • To investigate the role of E2F transcription factors in regulating PACE4 and its isoforms in prostate cancer.
  • To elucidate the mechanism of action and transcriptional control of PACE4 in the context of prostate cancer.

Main Methods:

  • In vitro molecular silencing studies were performed in prostate cancer cell lines.
  • PACE4 expression levels were analyzed following E2F manipulation.

Main Results:

  • E2F transcription factors alone did not significantly alter PACE4 expression levels in the studied prostate cancer cell lines.
  • This suggests that E2Fs are not the primary regulators of PACE4 expression in this context.

Conclusions:

  • The study indicates that E2F transcription factors are not involved in the direct transcriptional regulation of PACE4 in prostate cancer.
  • Further research is needed to identify the specific regulators of PACE4 and its isoforms to advance therapeutic strategies.
Keywords:
ARN interférantE2FPACE4TCGAcancer de la prostateconvertase de proprotéinesproprotein convertaseprostate cancersiRNAtransfection

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.2K
Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

707

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.1K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K